
Sign up to save your podcasts
Or


▶ Explore this week’s Tape — live, sortable, drill-down →
Three Bottlenecks, One Multiple, and Only One Monopoly
The AI argument flipped sides this week. For two years the only question that mattered was whether anyone would actually buy all this compute, and Wednesday’s show put that one to bed. The question left standing is whether the supply chain can physically build it — the lithography, the power, the memory. And in the rush to own the chokepoints, the market did something lazy. It paid all three the same monopoly multiple. Only one of them is a monopoly.
Start with the one that is. ASML makes the machine that etches the most advanced chips on earth, and it makes it alone — no second source, no roadmap to one, no credible challenger inside a decade. The Cash Flow Memo has it trading around sixty times free cash flow, on roughly eleven billion dollars of trailing free cash flow translated from euros.¹² That is a monopoly multiple, and for once it is bolted to an actual monopoly. The thing that can dent it is not a competitor — it is a government. Commerce Secretary Howard Lutnick told ASML, per Bloomberg, that he is concerned a top-tier extreme-ultraviolet machine may have reached China in violation of export controls; the company denied it has ever shipped one there.³ Notice what the risk actually is. Not the machine. The map of who is allowed to buy it. ASML’s customer list is the only variable that has ever moved this stock, and it is the one variable ASML does not control.
Now the two the market is paying as if they were ASML. GE Vernova booked more data-center power orders last quarter than it did in all of the prior year, and its turbine backlog now stretches past a hundred-ten gigawatts into 2029.⁴⁵ Free cash flow grew almost four hundred percent.⁶ Real demand, real scarcity — for now. But a gas turbine is not an EUV machine. Siemens Energy and Mitsubishi build them too, and slot scarcity is the kind of bottleneck competition fills in three or four years, not three or four decades. GE Vernova is renting its scarcity. The order book is genuine; the durability is the open question, and a thirty-times multiple is pricing the scarcity as if it were permanent.
Then memory — the bottleneck with the longest rap sheet. Micron reports Wednesday with its entire 2026 high-bandwidth-memory output already sold under contract and DRAM pricing set to jump fifty percent this quarter.⁷⁸ The cashflow read is in Marcus’s column below — short version, the trailing multiple is the cheap number, not the scary one. But here is the part the show had no room for: memory is the one bottleneck on this list that has detonated itself before. Every prior cycle ended the same way. All three makers see the shortage, all three turn the capex spigot at once, supply overshoots demand, and the pricing that looked structural turns out to have been a moment. Micron is committing roughly two hundred billion dollars to new capacity, and its two competitors are spending into the same shortage.⁹ That is either supply discipline or the seed of the next glut, and you cannot tell which from inside the shortage. You never can. That is what makes memory memory.
So three bottlenecks, three very different half-lives, and a tape paying all three the monopoly rate. The durable one — the cornered machine — arguably earns it. The other two are borrowing the multiple from the durable one, and the loan comes due the day a competitor adds a turbine line or a third memory maker blinks first on capex.
What changes the read is Wednesday, and the tell is Micron’s gross-margin guide. Guide above where consensus already sits and the cycle is still accelerating into the glut question, not away from it.¹⁰ Merely meet it, and a sold-out company that only meets gets sold on the news. The trade across the whole supply chain breaks the moment any one of the three memory makers signals it is racing the other two to fill capacity rather than pacing itself.
Wall Street’s consensus on the supply chain: own the bottleneck, any bottleneck, at any multiple. The math says own the one nobody else can build — and rent the other two only as long as the scarcity lasts.
The Tape — W2625
Universe of 94 cashflow-memo names, snap dates 2026-06-15 → 2026-06-19. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.
Telltales Yield — Top 10
From the Cashflow Desk — Marcus Graham
Micron reports Wednesday, and the reporters table holds the whole argument in two cells that read like a contradiction: a 1.0% trailing FCF yield sitting right beside 64% forward revenue growth. Trailing, Micron screens at 102x free cash flow — and that is a cyclical at the bottom of its cash cycle, where the trailing multiple measures the past and tells you nothing about the print. The 1.0% yield is the trough. The 64% is the market pricing what sold-out capacity earns once contract prices reset higher. The cheap-looking cell is the lie; the expensive-looking one is the tell. The test Wednesday is the gross-margin guide — clear where consensus already sits with the cycle still accelerating, or a sold-out name that merely meets gets sold on the news.
Telltales Yield — Bottom 10
This Week’s Reporters
Sector Medians
Debt / FCF Watch (highest leverage on TTM FCF)
Weekly Price Movement
Top 5 (week-over-week price)
Bottom 5 (week-over-week price)
Banks (shown separately — FCF metric not meaningful)
Finance-book — FCF not comparable
Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.
Data Gaps
90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).
Source: cashflow-memo master_2026-06-19.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.
The Issue — This Week's Brief
The Cashflow Memo
The Week AI Became a Supply Story
The bottleneck moved from demand to supply this week. Micron’s Wednesday print is the first real test.
The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2626.
Chapter markers
* Time | Segment
* 0:15 | Cold open — the supply side of AI
* 0:45 | Theme — the two hardest things to build (ASML, GE Vernova)
* 4:45 | Deep dive — Micron, the print that sets the cycle
* 8:45 | Rapid-fire — Moderna, FedEx, Nike, Cheniere, Intel
* 11:45 | Close — Consensus Watch + the week ahead
Full transcript
Opening disclaimer
Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.
Cold open
Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.
Marcus: And I’m Marcus Graham — the cashflow desk.
Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. This is still a pilot, so tell us what’s working and what isn’t.
Ava: And one more thing before we start — this one lands on Father’s Day. So happy Father’s Day to all the dads listening. We’re glad you’re spending part of the morning with us.
Ava: Here’s the week in one sentence. The argument about whether anyone will actually buy all this AI compute? That got settled on Wednesday’s show. This week the question flipped to the other side of the ledger — can we build the supply. The machines that print the chips, the power that runs them, and the memory that feeds them. All three flashed at once. Three different stories, one spine — the build is now gated by what can physically be manufactured, not by whether the demand shows up. On this week’s Telltales, episode 2625, Hunt, Jason, and Mike spent the hour on the demand side — NVIDIA at $5 trillion, the end of the subsidized-token era, who actually pays for the compute.[^ep-e2625b] We’re taking the other half. The supply chain that has to deliver before any of that demand means a thing.
Theme — The two hardest things to build
Ava: Two things in this build are genuinely hard to make. One is the machine that etches the chip. The other is the electricity that runs it. Both made news this week, and both made it for the same reason — the demand has gotten ahead of the supply. Start with the machine almost nobody owns. This week the US government told the company that makes it that one of those machines may have ended up somewhere it isn’t allowed to go. US Commerce Secretary Howard Lutnick told ASML’s leadership he’s concerned one of its top-tier extreme-ultraviolet lithography machines may have reached China, in violation of export controls.[^asml-us-export-concern-20260619] ASML denied it flatly — says it has never shipped an EUV machine to China.[^asml-us-export-concern-20260619] This on the same company that just raised its full-year guide to €36–40 billion on AI demand.[^asml-q1-earnings-20260619] Marcus — what does a monopoly on the most important machine in the world actually cost?
Marcus: ASML is the only company on earth that can make this machine, and the market has always paid it like one. The memo has ASML at about 62 times free cash flow,[^memo-asml-evfcf-20260619] on roughly $11 billion of trailing free cash flow, translated from euros.[^memo-asml-fcf-20260619] That’s a monopoly multiple for a monopoly. The export-control story doesn’t touch the cash — it touches who’s allowed to be a customer. And for this name, the customer list is the only variable that has ever mattered. A monopoly is worth 62 times right up until a government starts deciding who it can sell to.
Ava: So the risk isn’t the machine. It’s the map of where it’s allowed to ship. And if Lutnick’s concern turns out to be real — if a top-tier machine genuinely reached China — the read-through isn’t just one company’s quarter. It’s that the export-control wall the entire AI-chip supply chain is built on has a crack in it.[^asml-us-export-concern-20260619] That’s the bigger story, and it’s why a denial isn’t the end of this one. Now the other hard thing — and it’s the boring one, right up until it’s the bottleneck. Electricity. GE Vernova booked more data-center power orders in a single quarter than it did in all of last year. $2.4 billion of electrification equipment orders for data centers in the first quarter alone.[^gev-data-center-orders-20260619] Its gas-turbine backlog now stretches past 110 gigawatts into 2029,[^gev-turbine-backlog-20260619] and Bernstein just opened coverage with an Outperform, calling it a play on the AI power boom.[^gev-bernstein-20260619] Marcus — second one. What’s the cash say?
Marcus: The power names spent a decade as widow-and-orphan utilities. GE Vernova just stopped being one. The memo has it at about 33 times free cash flow,[^memo-gev-evfcf-20260619] and free cash flow grew almost 400% year over year.[^memo-gev-fcf-20260619] That’s not a utility growth rate — that’s an order book repricing to AI in real time. $2.4 billion of data-center orders in one quarter[^gev-data-center-orders-20260619] is the tell. The thing I’d watch is conversion: that backlog only matters if the turbine slots actually deliver on schedule and don’t slip. The orders are real. The execution is the open question.
Deep dive — Micron
Ava: Now the print that sets the whole cycle. Micron — page 5 of the memo, sharing it with GE Vernova, power and memory side by side — reports Wednesday after the close,[^earn-mu] and the question isn’t whether they beat. The question is whether there’s any memory left to sell. Because Micron’s entire 2026 high-bandwidth-memory production is already sold out — every chip, under binding contract, before the year is even half over.[^mu-hbm-sold-out-20260619] And DRAM contract pricing is set to jump 50–55% this quarter alone versus the end of last year.[^mu-dram-pricing-cycle-20260619] Marcus — when the product’s sold out a year ahead, what are we actually pricing?
Marcus: Here’s the trap on this one. Trailing, Micron screens at 102 times free cash flow.[^memo-mu-evfcf-20260619] Ignore that number. It’s a cyclical at the bottom of its cash-flow cycle, and a trailing multiple on a cyclical at the trough is noise — it tells you about the past, not the print. Free cash flow already grew more than 500% off the bottom,[^memo-mu-fcf-20260619] and the forward revenue line is up about 64%.[^memo-mu-ntmrev-20260619] You don’t value this on what it earned. You value it on what sold-out capacity earns at much higher pricing. And against that, 102 times trailing is the cheap number, not the scary one.
Ava: So the terrifying multiple is the cheap one. Marcus’s favorite kind of sentence.
Marcus: It is. And the supply side is the part the bears can’t model. Micron is committing roughly $200 billion to new capacity.[^mu-capex-expansion-20260619] You do not put $200 billion against a cycle you think is about to roll over. That’s management telling you the shortage is structural, not a head-fake. It’s the same story Nvidia’s Rubin platform is telling from the other side of the table — Micron is the qualified high-bandwidth-memory supplier into it, shipping in volume.[^mu-rubin-hbm4-20260619]
Ava: And the hiring backs it up.
Marcus: It does. Per the Talnexis hiring tracker, Micron is the #3 hiring floor on the entire board — 3,000 open roles, 181 of them added just this week.[^tlnx-mu-hiringfloor-20260619] You don’t staff like that into a cycle you expect to break. The one thing I’d actually watch Wednesday is the gross-margin guide — guide above where consensus already sits[^mu-margin-guidance-20260619] and the cycle’s still accelerating. Merely meet it and the stock’s already there, and a sold-out company that only meets is a sell-the-news.
Ava: So what actually breaks this?
Marcus: Two things, and I’d weight them. The real risk was never demand — it’s supply discipline. If all three memory makers turn the capex spigot at once, you get a glut, and the cycle ends the way every memory cycle has ended. I’d put that around 30%. The nearer risk is mix — if high-bandwidth memory crowds out standard DRAM capacity, the blended margin doesn’t reach what the Street’s penciling in. Call that another 10%. Which leaves the base case at 60% — and it’s the boring one: sold out, pricing up 50%, the capacity already committed. The cash shows up whether the multiple believes it or not.
Ava: So 30% it ends in tears, 10% it just muddles through on margin, 60% it prints money — and Marcus will at least give you the whole distribution instead of selling you a price target. 81% gross margin on what used to be a commodity.[^mu-margin-guidance-20260619] Read that twice. Broadcom and Oracle spent Wednesday’s show proving the demand is real.[^ep-e2625b] Micron on Wednesday tells you whether the supply can keep up. Same trade, opposite end of the table.
Rapid-fire
Ava: Rapid-fire. Five names, and markets open Monday.
Ava: Moderna had its best week in four years, and for once it had nothing to do with COVID. An FDA advisory panel voted 9-0 to endorse its mRNA flu vaccine for adults 50 and older,[^mrna-flu-vaccine-approval-20260619] with a final FDA decision expected by August 5. The stock jumped 28%.[^mrna-stock-jump-20260619] Free cash flow is still negative here — this is an optionality name, not a cash machine — but it’s the first real commercial catalyst since the COVID franchise rolled over.
Ava: Two reporters sit together on page 17 of the memo, and they’re back to back next week. FedEx is first, Tuesday after the close.[^earn-fdx] The number that matters isn’t the quarter — it’s the breakup. The Freight spinoff is on track: 80.1% of the shares distributed to FedEx holders, and Freight pays a $4.1 billion special dividend back to the parent on the way out.[^fdx-freight-spinoff-taxfree-20260619] Add $1 billion of cost cuts this year from the DRIVE program,[^fdx-drive-program-20260619] and a forward guide that just got raised.[^fdx-guidance-raise-20260619] A cleaner, lighter FedEx is the entire thesis.
Ava: Nike reports the following Tuesday, June 30.[^earn-nke] This is the clearest test yet of whether Elliott Hill’s turnaround is real. The headwinds are brutal — a $1.5 billion annual tariff hit that took gross margin down 300 basis points,[^nke-tariff-cost-20260619] China down 16%,[^nke-china-decline-20260619] digital down 14%.[^nke-digital-decline-20260619] Win Now has to show up in a number Tuesday, not a slogan. First place it can.
Ava: Cheniere keeps building while everyone else watches the oil price. It signed a $4.69 billion engineering contract with Bechtel for the Sabine Pass expansion,[^lng-sabine-pass-epc-20260619] with a final investment decision targeted for early 2027, and it just finished Corpus Christi Trains 5 and 6.[^lng-corpus-christi-progress-20260619] And it throws off nearly an 8% free-cash-flow yield while it does it.[^memo-lng-fcfyield-20260619] The cash machine of the energy names.
Ava: And Intel had a genuinely good week on the factory floor — which is the only place that matters for this story. Its 18A-P process entered risk production: 9% more performance at the same power.[^intc-18ap-20260619] And NVIDIA is evaluating that node for a future design.[^intc-nvidia-18a-20260619] No order yet. But the whole Intel thesis comes down to whether anyone outside Intel will manufacture on its leading node — and NVIDIA kicking the tires is the first real evidence in years.
Ava: And one to file away for the fall. Vertex got its kidney-disease drug, povetacicept, accepted for FDA review this week — its first real move into a major indication beyond cystic fibrosis, with a decision due November 30.[^vrtx-povetacicept-20260619] Not a Monday catalyst. But a real one on the calendar.
Close
Ava: That’s the show. Wall Street’s consensus on Micron heading into Wednesday: 30 analysts, unanimous Buy, an average target around $1,015 on a stock that’s already there.[^mu-analyst-target-revisions-20260619] Consensus says the supercycle is priced in. Consensus has been wrong about memory at every single turn of this cycle. Hiring data this week from Talnexis — talnexis.com. The throughline one more time: the AI demand debate is over. Whether the supply chain can deliver — the lithography, the power, the memory — is the only question left, and Wednesday’s Micron print is the first real answer. Hunt, Jason, and Mike are back Wednesday on episode 2626, picking up whether proprietary data can actually be protected.[^ep-e2625b] Download the Cash Flow Memo at telltales.us. I’m Ava Cabot. Thanks for listening.
Closing disclaimer
Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.
Sources
* ASML Holding. (2026). Q1 2026 financial results [Press release]. https://www.asml.com/en/news/press-releases/2026/q1-2026-financial-results
* Barchart. (2026). FedEx’s Q4 2026 earnings: What to expect. https://www.barchart.com/story/news/1533352/fedex-s-q4-2026-earnings-what-to-expect
* Bernstein / CNBC. (2026, June 16). GE Vernova (GEV) quote and analyst coverage. CNBC. https://www.cnbc.com/quotes/GEV
* Cheniere Energy. (2026). Corpus Christi liquefaction project. https://www.cheniere.com/about/where-we-work/ccl
* FDA panel recommends Moderna’s mRNA flu shot for older adults. (2026). NBC News. https://www.nbcnews.com/health/health-news/fda-panel-recommends-modernas-mrna-flu-shot-older-adults-rcna350699
* FedEx. (2026). FedEx Board of Directors approves spin-off of FedEx Freight [Investor news]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx
* FXLeaders. (2026, June 19). Micron earnings preview: MU stock faces key test as earnings approach. https://www.fxleaders.com/news/2026/06/19/micron-earnings-preview-mu-stock-faces-key-test-as-earnings-approach-after-strong-rally/
* Micron sold out of 2026 HBM. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/news/micron-sold-2026-hbm-us-231248051.html
* Micron Technology (MU) price target. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/micron-technology-mu-price-target-011038074.html
* Micron Technology (MU) wins HBM4 for Nvidia Vera Rubin. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/technology/ai/articles/micron-technology-mu-wins-hbm4-211205119.html
* Micron Technology: HBM sold out for 2026 — Wall Street is still underpricing. (2026, June 19). Seeking Alpha. https://seekingalpha.com/article/4881338-micron-technology-hbm-sold-out-for-2026-wall-street-is-still-underpricing
* Nike China guidance reset. (2026). AInvest. https://www.ainvest.com/news/nike-china-guidance-reset-term-pain-confirms-deep-rooted-inventory-demand-headwinds-2604/
* Nike stock 2026: NKE turnaround analysis. (2026). Top1Markets. https://www.top1markets.com/news/nike-stock-2026-nke-turnaround-analysis-elliott-hill
* Sabine Pass LNG expansion contract. (2026). Simply Wall St. https://simplywall.st/stocks/us/energy/nyse-lng/cheniere-energy/news/sabine-pass-lng-expansion-contract-might-change-the-case-for
* STAT Times. (2026). FedEx to reduce cost by $1bn in FY2026; net income drops 5% in FY2025. https://www.stattimes.com/air-cargo/fedex-to-reduce-cost-by-1bn-in-fy2026-net-income-drops-5-in-fy2025-1355655
* Supply Chain Dive. (2026). Nike’s $1.5B tariff hit and sourcing shift. https://www.supplychaindive.com/news/nike-1b-tariff-sourcing-price-hikes/752159/
* The end of cheap memory: Why 2026 marks a structural shift in tech economics. (2026, June 19). Investing.com. https://www.investing.com/analysis/the-end-of-cheap-memory-why-2026-marks-a-structural-shift-in-tech-economics-200675634
* The Register. (2026, June 17). Intel starts cooking up enhanced 18A-P silicon for would-be foundry customers. https://www.theregister.com/systems/2026/06/17/intel-starts-cooking-up-enhanced-18a-p-silicon-for-would-be-foundry-customers/5257487
* Timothy Sykes. (2026, June 17). Moderna Inc. (MRNA) news. https://www.timothysykes.com/news/moderna-inc-mrna-news-2026_06_17/
* US tells ASML it is concerned China may have top chip tool. (2026, June 19). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-19/us-tells-asml-it-s-concerned-china-may-have-top-chip-tool
* Utility Dive. (2026). GE Vernova bullish on electrical infrastructure as turbine backlog grows. https://www.utilitydive.com/news/ge-vernova-bullish-on-electrical-infrastructure-as-turbine-backlog-grows/803631/
* Utility Dive. (2026). GE Vernova expects to end 2025 with an 80 GW gas turbine backlog that stretches into 2029. https://www.utilitydive.com/news/ge-vernova-expects-to-end-2025-with-an-80-gw-gas-turbine-backlog-that-stretches-into-2029/807662/
* Vertex Pharmaceuticals. (2026). Vertex announces US FDA acceptance of biologics license application for povetacicept [Press release]. https://news.vrtx.com/news-releases/news-release-details/vertex-announces-us-fda-acceptance-biologics-license-application
* Yahoo Finance. (2026). Intel bets on 18A, Xeon 6. https://finance.yahoo.com/sectors/technology/articles/intel-bets-18a-xeon-6-070403655.html
Internal data
Internal data is provided on a best efforts basis.
Forward earnings
* FDX — FedEx, 2026-06-23 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 5.91 / revenue $24.04B. Earnings calendar.
* MU — Micron, 2026-06-24 (Wednesday) AMC, fiscal Q3 2026. (Consensus columns unreliable this week; report date verified.) Earnings calendar.
* NKE — Nike, 2026-06-30 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 0.11 / revenue $10.85B. Earnings calendar.
Hiring intelligence (Talnexis)
* MU — Micron #3 hiring floor (3,061 open roles, +181 in the 7-day window), detected 2026-06-19. Source: Talnexis hiring intelligence, https://www.talnexis.com/
By by Top Mark Capital5
66 ratings
▶ Explore this week’s Tape — live, sortable, drill-down →
Three Bottlenecks, One Multiple, and Only One Monopoly
The AI argument flipped sides this week. For two years the only question that mattered was whether anyone would actually buy all this compute, and Wednesday’s show put that one to bed. The question left standing is whether the supply chain can physically build it — the lithography, the power, the memory. And in the rush to own the chokepoints, the market did something lazy. It paid all three the same monopoly multiple. Only one of them is a monopoly.
Start with the one that is. ASML makes the machine that etches the most advanced chips on earth, and it makes it alone — no second source, no roadmap to one, no credible challenger inside a decade. The Cash Flow Memo has it trading around sixty times free cash flow, on roughly eleven billion dollars of trailing free cash flow translated from euros.¹² That is a monopoly multiple, and for once it is bolted to an actual monopoly. The thing that can dent it is not a competitor — it is a government. Commerce Secretary Howard Lutnick told ASML, per Bloomberg, that he is concerned a top-tier extreme-ultraviolet machine may have reached China in violation of export controls; the company denied it has ever shipped one there.³ Notice what the risk actually is. Not the machine. The map of who is allowed to buy it. ASML’s customer list is the only variable that has ever moved this stock, and it is the one variable ASML does not control.
Now the two the market is paying as if they were ASML. GE Vernova booked more data-center power orders last quarter than it did in all of the prior year, and its turbine backlog now stretches past a hundred-ten gigawatts into 2029.⁴⁵ Free cash flow grew almost four hundred percent.⁶ Real demand, real scarcity — for now. But a gas turbine is not an EUV machine. Siemens Energy and Mitsubishi build them too, and slot scarcity is the kind of bottleneck competition fills in three or four years, not three or four decades. GE Vernova is renting its scarcity. The order book is genuine; the durability is the open question, and a thirty-times multiple is pricing the scarcity as if it were permanent.
Then memory — the bottleneck with the longest rap sheet. Micron reports Wednesday with its entire 2026 high-bandwidth-memory output already sold under contract and DRAM pricing set to jump fifty percent this quarter.⁷⁸ The cashflow read is in Marcus’s column below — short version, the trailing multiple is the cheap number, not the scary one. But here is the part the show had no room for: memory is the one bottleneck on this list that has detonated itself before. Every prior cycle ended the same way. All three makers see the shortage, all three turn the capex spigot at once, supply overshoots demand, and the pricing that looked structural turns out to have been a moment. Micron is committing roughly two hundred billion dollars to new capacity, and its two competitors are spending into the same shortage.⁹ That is either supply discipline or the seed of the next glut, and you cannot tell which from inside the shortage. You never can. That is what makes memory memory.
So three bottlenecks, three very different half-lives, and a tape paying all three the monopoly rate. The durable one — the cornered machine — arguably earns it. The other two are borrowing the multiple from the durable one, and the loan comes due the day a competitor adds a turbine line or a third memory maker blinks first on capex.
What changes the read is Wednesday, and the tell is Micron’s gross-margin guide. Guide above where consensus already sits and the cycle is still accelerating into the glut question, not away from it.¹⁰ Merely meet it, and a sold-out company that only meets gets sold on the news. The trade across the whole supply chain breaks the moment any one of the three memory makers signals it is racing the other two to fill capacity rather than pacing itself.
Wall Street’s consensus on the supply chain: own the bottleneck, any bottleneck, at any multiple. The math says own the one nobody else can build — and rent the other two only as long as the scarcity lasts.
The Tape — W2625
Universe of 94 cashflow-memo names, snap dates 2026-06-15 → 2026-06-19. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.
Telltales Yield — Top 10
From the Cashflow Desk — Marcus Graham
Micron reports Wednesday, and the reporters table holds the whole argument in two cells that read like a contradiction: a 1.0% trailing FCF yield sitting right beside 64% forward revenue growth. Trailing, Micron screens at 102x free cash flow — and that is a cyclical at the bottom of its cash cycle, where the trailing multiple measures the past and tells you nothing about the print. The 1.0% yield is the trough. The 64% is the market pricing what sold-out capacity earns once contract prices reset higher. The cheap-looking cell is the lie; the expensive-looking one is the tell. The test Wednesday is the gross-margin guide — clear where consensus already sits with the cycle still accelerating, or a sold-out name that merely meets gets sold on the news.
Telltales Yield — Bottom 10
This Week’s Reporters
Sector Medians
Debt / FCF Watch (highest leverage on TTM FCF)
Weekly Price Movement
Top 5 (week-over-week price)
Bottom 5 (week-over-week price)
Banks (shown separately — FCF metric not meaningful)
Finance-book — FCF not comparable
Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.
Data Gaps
90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).
Source: cashflow-memo master_2026-06-19.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.
The Issue — This Week's Brief
The Cashflow Memo
The Week AI Became a Supply Story
The bottleneck moved from demand to supply this week. Micron’s Wednesday print is the first real test.
The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2626.
Chapter markers
* Time | Segment
* 0:15 | Cold open — the supply side of AI
* 0:45 | Theme — the two hardest things to build (ASML, GE Vernova)
* 4:45 | Deep dive — Micron, the print that sets the cycle
* 8:45 | Rapid-fire — Moderna, FedEx, Nike, Cheniere, Intel
* 11:45 | Close — Consensus Watch + the week ahead
Full transcript
Opening disclaimer
Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.
Cold open
Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.
Marcus: And I’m Marcus Graham — the cashflow desk.
Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. This is still a pilot, so tell us what’s working and what isn’t.
Ava: And one more thing before we start — this one lands on Father’s Day. So happy Father’s Day to all the dads listening. We’re glad you’re spending part of the morning with us.
Ava: Here’s the week in one sentence. The argument about whether anyone will actually buy all this AI compute? That got settled on Wednesday’s show. This week the question flipped to the other side of the ledger — can we build the supply. The machines that print the chips, the power that runs them, and the memory that feeds them. All three flashed at once. Three different stories, one spine — the build is now gated by what can physically be manufactured, not by whether the demand shows up. On this week’s Telltales, episode 2625, Hunt, Jason, and Mike spent the hour on the demand side — NVIDIA at $5 trillion, the end of the subsidized-token era, who actually pays for the compute.[^ep-e2625b] We’re taking the other half. The supply chain that has to deliver before any of that demand means a thing.
Theme — The two hardest things to build
Ava: Two things in this build are genuinely hard to make. One is the machine that etches the chip. The other is the electricity that runs it. Both made news this week, and both made it for the same reason — the demand has gotten ahead of the supply. Start with the machine almost nobody owns. This week the US government told the company that makes it that one of those machines may have ended up somewhere it isn’t allowed to go. US Commerce Secretary Howard Lutnick told ASML’s leadership he’s concerned one of its top-tier extreme-ultraviolet lithography machines may have reached China, in violation of export controls.[^asml-us-export-concern-20260619] ASML denied it flatly — says it has never shipped an EUV machine to China.[^asml-us-export-concern-20260619] This on the same company that just raised its full-year guide to €36–40 billion on AI demand.[^asml-q1-earnings-20260619] Marcus — what does a monopoly on the most important machine in the world actually cost?
Marcus: ASML is the only company on earth that can make this machine, and the market has always paid it like one. The memo has ASML at about 62 times free cash flow,[^memo-asml-evfcf-20260619] on roughly $11 billion of trailing free cash flow, translated from euros.[^memo-asml-fcf-20260619] That’s a monopoly multiple for a monopoly. The export-control story doesn’t touch the cash — it touches who’s allowed to be a customer. And for this name, the customer list is the only variable that has ever mattered. A monopoly is worth 62 times right up until a government starts deciding who it can sell to.
Ava: So the risk isn’t the machine. It’s the map of where it’s allowed to ship. And if Lutnick’s concern turns out to be real — if a top-tier machine genuinely reached China — the read-through isn’t just one company’s quarter. It’s that the export-control wall the entire AI-chip supply chain is built on has a crack in it.[^asml-us-export-concern-20260619] That’s the bigger story, and it’s why a denial isn’t the end of this one. Now the other hard thing — and it’s the boring one, right up until it’s the bottleneck. Electricity. GE Vernova booked more data-center power orders in a single quarter than it did in all of last year. $2.4 billion of electrification equipment orders for data centers in the first quarter alone.[^gev-data-center-orders-20260619] Its gas-turbine backlog now stretches past 110 gigawatts into 2029,[^gev-turbine-backlog-20260619] and Bernstein just opened coverage with an Outperform, calling it a play on the AI power boom.[^gev-bernstein-20260619] Marcus — second one. What’s the cash say?
Marcus: The power names spent a decade as widow-and-orphan utilities. GE Vernova just stopped being one. The memo has it at about 33 times free cash flow,[^memo-gev-evfcf-20260619] and free cash flow grew almost 400% year over year.[^memo-gev-fcf-20260619] That’s not a utility growth rate — that’s an order book repricing to AI in real time. $2.4 billion of data-center orders in one quarter[^gev-data-center-orders-20260619] is the tell. The thing I’d watch is conversion: that backlog only matters if the turbine slots actually deliver on schedule and don’t slip. The orders are real. The execution is the open question.
Deep dive — Micron
Ava: Now the print that sets the whole cycle. Micron — page 5 of the memo, sharing it with GE Vernova, power and memory side by side — reports Wednesday after the close,[^earn-mu] and the question isn’t whether they beat. The question is whether there’s any memory left to sell. Because Micron’s entire 2026 high-bandwidth-memory production is already sold out — every chip, under binding contract, before the year is even half over.[^mu-hbm-sold-out-20260619] And DRAM contract pricing is set to jump 50–55% this quarter alone versus the end of last year.[^mu-dram-pricing-cycle-20260619] Marcus — when the product’s sold out a year ahead, what are we actually pricing?
Marcus: Here’s the trap on this one. Trailing, Micron screens at 102 times free cash flow.[^memo-mu-evfcf-20260619] Ignore that number. It’s a cyclical at the bottom of its cash-flow cycle, and a trailing multiple on a cyclical at the trough is noise — it tells you about the past, not the print. Free cash flow already grew more than 500% off the bottom,[^memo-mu-fcf-20260619] and the forward revenue line is up about 64%.[^memo-mu-ntmrev-20260619] You don’t value this on what it earned. You value it on what sold-out capacity earns at much higher pricing. And against that, 102 times trailing is the cheap number, not the scary one.
Ava: So the terrifying multiple is the cheap one. Marcus’s favorite kind of sentence.
Marcus: It is. And the supply side is the part the bears can’t model. Micron is committing roughly $200 billion to new capacity.[^mu-capex-expansion-20260619] You do not put $200 billion against a cycle you think is about to roll over. That’s management telling you the shortage is structural, not a head-fake. It’s the same story Nvidia’s Rubin platform is telling from the other side of the table — Micron is the qualified high-bandwidth-memory supplier into it, shipping in volume.[^mu-rubin-hbm4-20260619]
Ava: And the hiring backs it up.
Marcus: It does. Per the Talnexis hiring tracker, Micron is the #3 hiring floor on the entire board — 3,000 open roles, 181 of them added just this week.[^tlnx-mu-hiringfloor-20260619] You don’t staff like that into a cycle you expect to break. The one thing I’d actually watch Wednesday is the gross-margin guide — guide above where consensus already sits[^mu-margin-guidance-20260619] and the cycle’s still accelerating. Merely meet it and the stock’s already there, and a sold-out company that only meets is a sell-the-news.
Ava: So what actually breaks this?
Marcus: Two things, and I’d weight them. The real risk was never demand — it’s supply discipline. If all three memory makers turn the capex spigot at once, you get a glut, and the cycle ends the way every memory cycle has ended. I’d put that around 30%. The nearer risk is mix — if high-bandwidth memory crowds out standard DRAM capacity, the blended margin doesn’t reach what the Street’s penciling in. Call that another 10%. Which leaves the base case at 60% — and it’s the boring one: sold out, pricing up 50%, the capacity already committed. The cash shows up whether the multiple believes it or not.
Ava: So 30% it ends in tears, 10% it just muddles through on margin, 60% it prints money — and Marcus will at least give you the whole distribution instead of selling you a price target. 81% gross margin on what used to be a commodity.[^mu-margin-guidance-20260619] Read that twice. Broadcom and Oracle spent Wednesday’s show proving the demand is real.[^ep-e2625b] Micron on Wednesday tells you whether the supply can keep up. Same trade, opposite end of the table.
Rapid-fire
Ava: Rapid-fire. Five names, and markets open Monday.
Ava: Moderna had its best week in four years, and for once it had nothing to do with COVID. An FDA advisory panel voted 9-0 to endorse its mRNA flu vaccine for adults 50 and older,[^mrna-flu-vaccine-approval-20260619] with a final FDA decision expected by August 5. The stock jumped 28%.[^mrna-stock-jump-20260619] Free cash flow is still negative here — this is an optionality name, not a cash machine — but it’s the first real commercial catalyst since the COVID franchise rolled over.
Ava: Two reporters sit together on page 17 of the memo, and they’re back to back next week. FedEx is first, Tuesday after the close.[^earn-fdx] The number that matters isn’t the quarter — it’s the breakup. The Freight spinoff is on track: 80.1% of the shares distributed to FedEx holders, and Freight pays a $4.1 billion special dividend back to the parent on the way out.[^fdx-freight-spinoff-taxfree-20260619] Add $1 billion of cost cuts this year from the DRIVE program,[^fdx-drive-program-20260619] and a forward guide that just got raised.[^fdx-guidance-raise-20260619] A cleaner, lighter FedEx is the entire thesis.
Ava: Nike reports the following Tuesday, June 30.[^earn-nke] This is the clearest test yet of whether Elliott Hill’s turnaround is real. The headwinds are brutal — a $1.5 billion annual tariff hit that took gross margin down 300 basis points,[^nke-tariff-cost-20260619] China down 16%,[^nke-china-decline-20260619] digital down 14%.[^nke-digital-decline-20260619] Win Now has to show up in a number Tuesday, not a slogan. First place it can.
Ava: Cheniere keeps building while everyone else watches the oil price. It signed a $4.69 billion engineering contract with Bechtel for the Sabine Pass expansion,[^lng-sabine-pass-epc-20260619] with a final investment decision targeted for early 2027, and it just finished Corpus Christi Trains 5 and 6.[^lng-corpus-christi-progress-20260619] And it throws off nearly an 8% free-cash-flow yield while it does it.[^memo-lng-fcfyield-20260619] The cash machine of the energy names.
Ava: And Intel had a genuinely good week on the factory floor — which is the only place that matters for this story. Its 18A-P process entered risk production: 9% more performance at the same power.[^intc-18ap-20260619] And NVIDIA is evaluating that node for a future design.[^intc-nvidia-18a-20260619] No order yet. But the whole Intel thesis comes down to whether anyone outside Intel will manufacture on its leading node — and NVIDIA kicking the tires is the first real evidence in years.
Ava: And one to file away for the fall. Vertex got its kidney-disease drug, povetacicept, accepted for FDA review this week — its first real move into a major indication beyond cystic fibrosis, with a decision due November 30.[^vrtx-povetacicept-20260619] Not a Monday catalyst. But a real one on the calendar.
Close
Ava: That’s the show. Wall Street’s consensus on Micron heading into Wednesday: 30 analysts, unanimous Buy, an average target around $1,015 on a stock that’s already there.[^mu-analyst-target-revisions-20260619] Consensus says the supercycle is priced in. Consensus has been wrong about memory at every single turn of this cycle. Hiring data this week from Talnexis — talnexis.com. The throughline one more time: the AI demand debate is over. Whether the supply chain can deliver — the lithography, the power, the memory — is the only question left, and Wednesday’s Micron print is the first real answer. Hunt, Jason, and Mike are back Wednesday on episode 2626, picking up whether proprietary data can actually be protected.[^ep-e2625b] Download the Cash Flow Memo at telltales.us. I’m Ava Cabot. Thanks for listening.
Closing disclaimer
Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.
Sources
* ASML Holding. (2026). Q1 2026 financial results [Press release]. https://www.asml.com/en/news/press-releases/2026/q1-2026-financial-results
* Barchart. (2026). FedEx’s Q4 2026 earnings: What to expect. https://www.barchart.com/story/news/1533352/fedex-s-q4-2026-earnings-what-to-expect
* Bernstein / CNBC. (2026, June 16). GE Vernova (GEV) quote and analyst coverage. CNBC. https://www.cnbc.com/quotes/GEV
* Cheniere Energy. (2026). Corpus Christi liquefaction project. https://www.cheniere.com/about/where-we-work/ccl
* FDA panel recommends Moderna’s mRNA flu shot for older adults. (2026). NBC News. https://www.nbcnews.com/health/health-news/fda-panel-recommends-modernas-mrna-flu-shot-older-adults-rcna350699
* FedEx. (2026). FedEx Board of Directors approves spin-off of FedEx Freight [Investor news]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx
* FXLeaders. (2026, June 19). Micron earnings preview: MU stock faces key test as earnings approach. https://www.fxleaders.com/news/2026/06/19/micron-earnings-preview-mu-stock-faces-key-test-as-earnings-approach-after-strong-rally/
* Micron sold out of 2026 HBM. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/news/micron-sold-2026-hbm-us-231248051.html
* Micron Technology (MU) price target. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/micron-technology-mu-price-target-011038074.html
* Micron Technology (MU) wins HBM4 for Nvidia Vera Rubin. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/technology/ai/articles/micron-technology-mu-wins-hbm4-211205119.html
* Micron Technology: HBM sold out for 2026 — Wall Street is still underpricing. (2026, June 19). Seeking Alpha. https://seekingalpha.com/article/4881338-micron-technology-hbm-sold-out-for-2026-wall-street-is-still-underpricing
* Nike China guidance reset. (2026). AInvest. https://www.ainvest.com/news/nike-china-guidance-reset-term-pain-confirms-deep-rooted-inventory-demand-headwinds-2604/
* Nike stock 2026: NKE turnaround analysis. (2026). Top1Markets. https://www.top1markets.com/news/nike-stock-2026-nke-turnaround-analysis-elliott-hill
* Sabine Pass LNG expansion contract. (2026). Simply Wall St. https://simplywall.st/stocks/us/energy/nyse-lng/cheniere-energy/news/sabine-pass-lng-expansion-contract-might-change-the-case-for
* STAT Times. (2026). FedEx to reduce cost by $1bn in FY2026; net income drops 5% in FY2025. https://www.stattimes.com/air-cargo/fedex-to-reduce-cost-by-1bn-in-fy2026-net-income-drops-5-in-fy2025-1355655
* Supply Chain Dive. (2026). Nike’s $1.5B tariff hit and sourcing shift. https://www.supplychaindive.com/news/nike-1b-tariff-sourcing-price-hikes/752159/
* The end of cheap memory: Why 2026 marks a structural shift in tech economics. (2026, June 19). Investing.com. https://www.investing.com/analysis/the-end-of-cheap-memory-why-2026-marks-a-structural-shift-in-tech-economics-200675634
* The Register. (2026, June 17). Intel starts cooking up enhanced 18A-P silicon for would-be foundry customers. https://www.theregister.com/systems/2026/06/17/intel-starts-cooking-up-enhanced-18a-p-silicon-for-would-be-foundry-customers/5257487
* Timothy Sykes. (2026, June 17). Moderna Inc. (MRNA) news. https://www.timothysykes.com/news/moderna-inc-mrna-news-2026_06_17/
* US tells ASML it is concerned China may have top chip tool. (2026, June 19). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-19/us-tells-asml-it-s-concerned-china-may-have-top-chip-tool
* Utility Dive. (2026). GE Vernova bullish on electrical infrastructure as turbine backlog grows. https://www.utilitydive.com/news/ge-vernova-bullish-on-electrical-infrastructure-as-turbine-backlog-grows/803631/
* Utility Dive. (2026). GE Vernova expects to end 2025 with an 80 GW gas turbine backlog that stretches into 2029. https://www.utilitydive.com/news/ge-vernova-expects-to-end-2025-with-an-80-gw-gas-turbine-backlog-that-stretches-into-2029/807662/
* Vertex Pharmaceuticals. (2026). Vertex announces US FDA acceptance of biologics license application for povetacicept [Press release]. https://news.vrtx.com/news-releases/news-release-details/vertex-announces-us-fda-acceptance-biologics-license-application
* Yahoo Finance. (2026). Intel bets on 18A, Xeon 6. https://finance.yahoo.com/sectors/technology/articles/intel-bets-18a-xeon-6-070403655.html
Internal data
Internal data is provided on a best efforts basis.
Forward earnings
* FDX — FedEx, 2026-06-23 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 5.91 / revenue $24.04B. Earnings calendar.
* MU — Micron, 2026-06-24 (Wednesday) AMC, fiscal Q3 2026. (Consensus columns unreliable this week; report date verified.) Earnings calendar.
* NKE — Nike, 2026-06-30 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 0.11 / revenue $10.85B. Earnings calendar.
Hiring intelligence (Talnexis)
* MU — Micron #3 hiring floor (3,061 open roles, +181 in the 7-day window), detected 2026-06-19. Source: Talnexis hiring intelligence, https://www.talnexis.com/